Efficacy and safety of mirodenafil, A new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction

Journal of Sexual Medicine

Volumn 5, Issue 11, 2008, Pages 2672-2680

  Paick, Jae Seung ^a   Ahn, Tai Y ^b   Choi, Hyung K ^c   Chung, Woo Sik ^d   Kim, Je J ^e   Kim, Sae C ^f   Kim, Sae W ^g   Lee, Sung W ^h   Min, Kweon S ⁱ   Moon, Ki H ^j   Park, Jong K ^k   Park, Kwangsung ^l   Park, Nam C ^m   Suh, Jun Kyu ⁿ   Yang, Dae Y ^o   Jung, Hyung Gi ^p  

^a Seoul National University Hospital   (South Korea)

^b Asan Medical Center   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Ewha Womans University   (South Korea)

^e Korea University Ansan Hospital   (South Korea)

^f Chung Ang University College of Medicine   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h Samsung Medical Center   (South Korea)

ⁱ Inje University College of Medicine   (South Korea)

^j Yeungnam University Hospital   (South Korea)

^k Chonbuk National University Medical School   (South Korea)

^l Chonnam National University Medical School   (South Korea)

^m Pusan National University Hospital   (South Korea)

ⁿ Inha University Hospital   (South Korea)

^o Hallym University Medical Center   (South Korea)

^p Seokyeong University   (South Korea)

more..

Author keywords

Erectile Dysfunction; Mirodenafil; PDE5

Indexed keywords

MIRODENAFIL; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHECKLIST; CLINICAL TRIAL; COLOR VISION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; ERECTILE DYSFUNCTION; EYE DISEASE; EYE REDNESS; FLUSHING; HEART PALPITATION; HUMAN; KOREA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PARALLEL DESIGN; PHYSICAL EXAMINATION; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEXUAL BEHAVIOR; SIDE EFFECT; THORAX PAIN; VITAL SIGN;

EID: 55849098428     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00945.x     Document Type: Article

References (22)

1. Hanson-Divers C, Jackson SE, Lue TF, Crawford SY, Rosen RC. Health outcomes variables important to patients in the treatment of erectile dysfunction. J Urol 1998; 159: 1541-7.
2. Souverein PC, Egberts AC, Meuleman EJ, Urquhart J, Leufkens HG. Incidence and determinants of sildenafil (dis)continuation: The Dutch cohort of sildenafil users. Int J Impot Res 2002; 14: 259-65.
3. Gonzalgo ML, Brotzman M, Trock BJ, Geringer AM, Burnett AL, Jarow JP. Clinical efficacy of sildenafil citrate and predictors of long-term response. J Urol 2003; 170: 503-6.
4. 14C-SK3530. 2 HCl) J Labelled Comp Radiopharm 2006; 49: 1141-9.
5. Lee J, Yoo HH, Rhim KJ, Sohn DR, Kim DH. Metabolism and excretion of 5-ethyl-2-{5-[4-(2-hydroxyethyl) piperazine-1-sulfonyl]-2-propoxyphenyl} -7-propyl-3,5-dihydropyrrolo[3,2-d]-pyrimidin-4-one (SK 3530) in rats. Rapid Commun Mass Spectrom 2007; 21: 1139-49.
6. Paick JS, Choi HK, Kim SC, Ahn TY, Kim JJ, Park NC, Park JK, Park KS, Lee SW. Efficacy and safety of oral SK3530 in the treatment of men in Korea with erectile dysfunction: A multicentre, randomized, double-blind, placebo-controlled, fixed dose, parallel group clinical trial. J Sex Med 2006;3 (5 suppl): 393.
7. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30.
8. Fugl-Meyer AR, Lodnert G, Branholm IB, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997; 9: 141-8.
9. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346-51.
10. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, Anglin G, Whitaker S. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses. J Urol 2002; 168: 1332-6.
11. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397-404.
12. Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H. Vardenafil for treatment of men with erectile dysfunction: Efficacy and safety in a randomized, double-blind, placebo-controlled trial. J Androl 2002; 23: 763-71.
13. Chen KK, Paick JS, Ishii N, Vardenafil Study Group. The efficacy and safety of vardenafil in East Asian men with erectile dysfunction. J Sex Med 2007; 4: 753-61.
14. Padma-Nathan H, McMurray JG, Pullman WE, Whitaker JS, Saoud JB, Ferguson KM, Rosen RC, IC351 On-Demand Dosing Study Group. On-demand IC351 (Cialis) enhances erectile function in patients with erectile dysfunction. Int J Impot Res 2001; 13: 2-9.
15. Althof SE, O'leary MP, Cappelleri JC, Hvidsten K, Stecher VJ, Glina S, King R, Siegel RL, International SEAR Study Group. Sildenafil citrate improves self-esteem, confidence, and relationships in men with erectile dysfunction: Results from an international, multi-center, double-blind, placebo-controlled trial. J Sex Med 2006; 3: 521-9.
16. Mulhall JP. Deciphering erectile dysfunction drug trials. J Urol 2003; 170: 353-8.
17. Eardley I, Gentile V, Austoni E, Hackett G, Lembo D, Wang C, Beardsworth A. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction. BJU Int 2004; 94: 871-7.
18. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54-61.
19. Choi HK, Ahn TY, Kim JJ, Kim SC, Paick JS, Suh JK, Kim HS, Kim YK, Lee WH, Oh BH, Park CH, Ryu WS, Chung TG, Kim SW, Lee WH, Moon DG, Ryu DS, Seo KK, Kim DK, Lee DS. A double-blind, randomized placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea. Int J Impot Res 2003; 15: 80-6.
20. Chen KK, Hsieh JT, Huang ST, Jiaan DB, Lin JS, Wang CJ. ASSESS-3: A randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan. Int J Impot Res 2001; 13: 221-9.
21. Nagao K, Ishii N, Kamidono S, Osada T; Vardenafil (Levitra) Clinical Trial Group. Safety and efficacy of vardenafil in patients with erectile dysfunction: Result of a bridging study in Japan. Int J Urol 2004; 11: 515-24.
22. Chen KK, Jiann BP, Lin JS, Lee SS, Huang ST, Wang CJ, Ju-Ton H, Su CK, Costigan TM, Emmick JT. Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: A randomized, double-blind, parallel, placebo-controlled clinical study. J Sex Med 2004; 1: 201-8.